The European Rare Disease Models & Mechanisms Network (RDMM-Europe) has been established by Solve-RD – an EU-funded research project. The overall aim is to boost research in rare diseases, discover new disease-causing genes and obtain evidence for pathogenicity through functional validation.

For more information, visit the following website.

The European Rare Disease Models & Mechanisms Network (RDMM-Europe) has been established by Solve-RD – an EU-funded research project. The overall aim is to boost research in rare diseases, discover new disease-causing genes and obtain evidence for pathogenicity through functional validation.

For more information, visit the following website.

A call on research and innovation's actions will be launched on July 18, 2019. IMI projects aim at accelerating the medicines development process, generating new scientific insights, and developing resources for open use by the research community. The topics of this call are related to integrated research platforms, digital clinical trials, immune-mediated diseases, medicines safety, brain disorders, blockchain, antimicrobial resistance.

FInd more information on the following link.

The International Summer School on Rare Disease Registries and FAIRification of Data is a part of a series of training activities proposed by the European Joint Programme on Rare Diseases (EJP RD) which will take place at the Istituto Superiore di Sanità, Rome, Italy. The first module “Rare Disease Registries” starts on September 23 till September 25, 2019. The second module “FAIRification of data”, starts on September 26 till September 27, 2019.

Onlne registration deadline is June 20th, 2019.

Find more information on the following link.

The European Joint Programme on Rare Diseases (EJP RD), which is the successor of E-Rare launches the Joint Transnational Call 2019. The call will  open officially in December. This year projects should focus on accelerated diagnosis and/or exploration of disease progression and mechanisms of rare diseases. More info under www.ejprarediseases.org

E-Rare Newsletter 10 Dec 2012

Having trouble reading this e-mail ? View it in your browser
ERA-Net for Research Programmes on Rare Diseases
E-Rare Newsletter 10 Dec 2012

On the 7th of December 2012 E-Rare opened its 5th Joint Transnational Call for Research Projects on Rare Diseases (JTC 2013). Fourteen countries have announced their participation: Austria, Belgium (Flanders and French speaking community), Canada (including Québec), France, Germany, Hungary, Israel, Italy, Poland, Portugal, Romania, Spain, Switzerland and Turkey.

The aim of the call is to enable scientists in different countries to build an effective collaboration on a common interdisciplinary research project based on complementarities and sharing of expertise, with a clear translational research approach. Projects shall involve a group of rare diseases or a single rare disease following the European definition i.e. a disease affecting not more than five in 10.000 persons in the European Community. Rare infectious diseases, rare cancers and rare adverse drug events in treatments of common diseases are excluded from the scope of this call.

Transnational research proposals must cover at least one of the following areas, which are equal in relevance for this call:
 


a) Collaborative research using patient databases and corresponding collections of biological material that would generally not be possible at a national scale. This research must have clear potential for clinical application and well defined scientific objectives e.g.:  

  • Definition of new nosological entities, epidemiological studies, genotype/phenotype correlations, natural history of diseases
  • Characterisation of the genetic/molecular basis of specific diseases

b) Research on rare diseases including genetic, epigenetic, and pathophysiological studies, using innovative and shared resources, technologies (OMICS, new generation sequencing, etc.) and expertises. The clinical relevance of this research must be clearly demonstrated.
c) Research on development of applications for diagnosis and therapies for rare diseases. This may include identification and characterisation of (bio)-markers for diagnosis and prognosis, development of innovative screening systems and diagnostic tools, the generation of relevant cellular and/or animal models, and preclinical studies using pharmacological, gene or cell therapies.
d) Patient oriented research in the area of social and human sciences - e.g. psychological, psychosocial and behavioural research - as well as health services, health economics and health policy research and research on ethical, legal and social issues in the field of rare disorders.

Interventional clinical trials are excluded from the scope of the call.

Project proposals must clearly demonstrate the potential health impact as well as the added-value of transnational collaboration: gathering a critical mass of patients/biological material, sharing of resources (models, databases, diagnosis etc.), harmonization of data, sharing of specific know-how and/or innovative technologies.


Joint research proposals may be submitted by higher education institutions, non-university public research establishments, hospitals as well as commercial companies, in particular small and medium-size enterprises (SMEs), according to relevant national funding organisations´ regulations for research funding. Whilst applications will be submitted jointly by groups from several countries, individual groups will be funded by the individual E-Rare-2 funding organisation respective of the country from which applicants have applied. The applications are therefore subjected to eligibility criteria of individual funding organisations. 
Applicants are strongly advised to contact their national representative and confirm eligibility with their respective funding organisations in advance of submitting an application.
Only transnational projects will be funded.

Each consortium must involve a minimum of three and a maximum of six research groups from at least three different countries participating to the call. Research groups from countries whose funding organisations are not partners in this E-Rare-2 call may participate in projects if they are able to secure their own funding. There must not be more than two research groups from the same country in one project proposal.

For more information, timeline and all necessary documents visit our website:

www.e-rare.eu

www.e-rare.eu contact@erare.eu

E-Rare 2012 - Created by Toussaint Biger